Sanofi SA
Healthcare · EUR · EPA
Price
€76.125
Cap
€96.29B
Earnings
—
30d Trend
+2.2%
43% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 64×Macro 0.99 (−1%)=63
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
6-9 month opportunity — emerging trend
BRAIN47'S ASSESSMENT
I rate Sanofi SA at 63/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 81/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.
PAST PERFORMANCE
1 MONTH
+4.9%
3 MONTHS
+1.6%
12 MONTHS
+59.5%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
6-9 month opportunity — emerging trend. Momentum (81) and Quality (60) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 43%. I classify this as a growth position — strong momentum combined with solid fundamentals points to capital appreciation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.